Curis
CRIS
#11126
Rank
A$3.84 M
Marketcap
A$1.59
Share price
0.00%
Change (1 day)
-37.57%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$34.90

According to Curis's latest financial reports the company's current EPS (TTM) is A-$33.42. In 2025 the company made an earnings per share (EPS) of A-$33.42 an increase over its 2024 EPS that were of A-$197.42.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$34.904.42%
2025A-$33.42-83.07%
2024A-$197.42-22.15%
2023A-$253.58-26.17%
2022A-$343.4422.3%
2021A-$280.82-25.37%
2020A-$376.30-30.93%
2019A-$544.79-2.02%
2018A-$556.02
2016A-$1,264-10%
2015A-$1,404138.1%
2014A-$589.7240%
2013A-$421.23-25%
2012A-$561.6466.67%
2011A-$336.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.84-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.00-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.39-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.98-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$7.08-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA